Company Overview

Development Stage

About the Company

微芯生物是一家以核心技术驱动,构建具有全球竞争力产品线的原创新药企业。作为中国原创新药领域的拓荒者,秉持“原创、安全、优效、中国”的理念,致力于为患者提供临床亟需的、具有革命性疗效的创新机制药物。公司已形成从早期探索性发现到商业化的完整产业链布局,为全球患者提供中国原创新药。基于中国早期研究的全球开发策略,微芯生物汇聚相关领域具有资深经验的顶尖科学家团队,应用基于AI辅助设计+化学基因组学的整合式技术平台,打通了从基础研究到临床转化的全过程,已成功开发出西达本胺(肿瘤)及西格列他钠(2型糖尿病)两款全球首创(First-in-)且同类*优(Best-in-)的原创新药,实现多个适应症在全球上市销售,且在恶性肿瘤、代谢性疾病、自身免疫性疾病、神经退行性疾病等领域布局了多个具有差异化优势和全球竞争力的研发项目。微芯生物拥有深圳总部/研发中心/GMP生产基地、成都区域总部/研发中心/GMP生产基地、彭州微芯药业、北京分公司、上海分公司及美国子公司 ThalassaX Therapeutics United States Ltd的全球化产业布局。同时,作为国家首批“创新药物孵化基地”、国家高新技术企业,公司独立承担多项国家“863”“十五”“十一五”“十二五”及“十三五”国家重大科技专项及“重大新药创制”项目,累计申请境内外发明专利800余项,250余项已获授权。我们的福利(1)提供带薪年假、带薪病假、家长会假等福利假期(2)试用期即发转正工资(3)绩效奖金+项目奖+季度奉献奖+创新奖等多样化奖励(4)技术晋升、管理晋升双通道(5)社保+住房公积金(按成都*高缴纳比例12%缴纳)+商业保险(含20万高保障重疾险,门诊亦可报销)(6)研发中心提供高级人才专家房等福利(7)生产基地提供免费午餐和温馨双人间住宿(8)提供午餐和交通等补贴(9)节日福利(10)月度、季度、年度多样化团建活动(11)年度全面健康体检工作时间:每周五天工作制:*生物医药,事关人类福祉,带着这样的使命感,我们在寻找志同道合的您!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (23 open positions)

Manage
Note: How fast is hiring at 成都微芯药业有限公司 growing? 2026: 37 openings (up 28%), 2025: 29 openings (down 9%), 2024: 32 openings (down 37%), 2023: 51 openings (up 467%), 2022: 9 openings (down 84%), 2021: 58 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 75%
  • 2024: Down 60%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 成都微芯药业有限公司 growing? Master's recruitment over the years: 2025: 1 openings (down 75%), 2024: 4 openings (down 60%), 2023: 10 openings, 2021: 2 openings.

Doctoral Degree Job Demand Analysis

(More)
+200%
Growth Rate
2026 vs 2025
Doctoral Hiring by Year: 2026 — 2 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 成都微芯药业有限公司 growing? Doctorate recruitment over the years: 2026: 3 openings (flat), 2025: 1 openings (down 75%), 2023: 7 openings, 2022: 3 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 成都微芯药业有限公司? Based on an analysis of 's job postings over the past year, "生物/制药/化工/环保类" demand: 31.3%, "其他(研发和技术类)": 12.5%, "科研类": 10.9%, "医疗卫生/美容保健类": 6.3%, "机械/仪器仪表类": 4.7%, "计算机/网络/技术类": 3.1%. For reference only.

— What Are the Salaries Like? (64 records)

Manage
salary range: 3K - 50K, 65.7% of roles pay ¥4.5-8K
Note: salary statistics are based on 64 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 成都微芯药业有限公司?65.7% of positions earn 4.5-8K, Undergraduate salary: ¥。工厂生产类 average salary ¥7.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 成都微芯药业有限公司? We provide: qc,qa,检验,研究员,车间,ehs,生产技术,it专员,分析,工程技术,库房,行政,设备主管,hr,仓库,会计,保洁,叉车,实习生,微生物主管. Click to view detailed salary analysis by job.

Related Industry Tags

Job Category

  • 工厂生产类
    68.8% of total 68.8%
  • 质量管理类
    32.8% of total 32.8%
  • 生物/制药/化工/环保类
    31.3% of total 31.3%
  • 经营管理类
    18.8% of total 18.8%

Education

  • 大专
    45.3% of total 45.3%
  • 本科
    32.8% of total 32.8%
  • 高中
    12.5% of total 12.5%
  • 博士
    6.3% of total 6.3%

Experience

  • 不限
    46.9% of total 46.9%
  • 3-5年
    23.4% of total 23.4%
  • 1-3年
    18.8% of total 18.8%
  • 5-10年
    10.9% of total 10.9%
View Detailed Analysis

What does 成都微芯药业有限公司 require? Who is 成都微芯药业有限公司 hiring? recruitment: 工厂生产类占比最多占68.8%,其次是质量管理类占32.8%. What education can get in at ? 大专占比最多占45.3%,其次是本科占32.8%. High education required at ? 博士占6.3%,硕士占1.6%. Work experience required at ? 不限占比最多占46.9%,其次是3-5年占23.4%. Where are the job locations at ? 成都占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 86,000万(元)
Legal Representative: XIANPING LU
Date Established:
Credit Code: 91510100098314955N
Registered Address: 中国(四川)自由贸易试验区成都高新区新通南一路18号

Partners & Suppliers

微芯生物通过广州医药渠道销售西达本胺,广州医药为微芯生物的主要分销商之一 Source
合作客户 药物销售/商业化合作
微芯生物通过上海医药渠道销售西达本胺,上海医药为微芯生物的主要分销商之一 Source
合作客户 药物销售/商业化合作
微芯生物通过南京医药渠道销售西达本胺,南京医药为微芯生物的主要分销商之一 Source
合作客户 药物销售/商业化合作
微芯生物通过国药控股渠道销售西达本胺,国药控股为微芯生物的主要分销商之一 Source
合作客户 药物销售/商业化合作
微芯生物通过华润医药渠道销售西达本胺,华润医药为微芯生物的主要分销商之一 Source
合作客户 药物销售/商业化合作

People who follow this company also follow

Competitors (Similar Companies)

“A pharmaceutical group committed to the research, development, product”
“Committed to providing patients with affordable innovative mechanism-b”
“Professional manufacturer and operator of large-volume parenteral solu”
“Let everyone have trust and expectation in Baili because of health!”
制药/药业 医药 医药工业 原料药
“A technology-driven international pharmaceutical enterprise”
医药 生物制品 化学制药 药物研发
“Adhering to the pursuit of high quality”
“To bring safer pharmaceutical technology achievements to every patient”
制药/药业 医药 原料药 抗肿瘤药
中药提取 原料药 生产 原料
医药 化妆品 医药中间体 原料药
“A high-standard, professional pharmaceutical enterprise group engaged ”
智能硬件 物联网/IoT 智能电网 光缆
“Vice-President Unit of China Pharmaceutical Industry Association”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates